CN Stock MarketDetailed Quotes

Beihai Gofar Chuanshan Biological (600538)

Watchlist
  • 6.51
  • -0.09-1.36%
Not Open Mar 26 15:00 CST
3.41BMarket Cap-44.29P/E (TTM)

Beihai Gofar Chuanshan Biological (600538) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Pharmaceutical circulation95.37M62.04%
DNA检测设备、耗材及检测服务34.06M22.16%
Pharmaceutical manufacturing12.74M8.29%
Judicial expertise9.56M6.22%
Total special adjustments1.6M1.04%
Other394.5K0.26%
View all

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical circulation182.64M53.64%
司法IVD118.73M34.87%
Pharmaceutical manufacturing35.45M10.41%
Other business2.16M0.64%
Other1.49M0.44%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic market152.02M98.89%
Total special adjustments1.71M1.11%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More